AstraZeneca and Sun Pharma will jointly market SZC, a key hyperkalaemia drug for CKD and heart failure patients, under ...

IonQ stock surges 600% as quantum computing revenue grows 222% to $40M. Learn about IonQ, Rigetti, and D-Wave's performance ...

Medicxi will use the €500m kitty to continue supporting drug hunters and entrepreneurs in creating asset-focused ...

Under the agreement, AstraZeneca will sell SZC under the brand Lokelma, while Sun Pharma will distribute it as Gimliand.

AstraZeneca will market the therapy as Lokelma, while Sun Pharma will promote and distribute it as Gimliand. AstraZeneca will ...

President Donald Trump keeps downplaying America’s affordability crisis, and he continues to falsely claim that inflation and ...

Traditionally, developing a new drug can take over a decade, but AI technology is changing that timeline. Major pharmaceutical companies like Pfizer and AstraZeneca are leveraging AI to accelerate the ...

Lexicon Pharmaceuticals targets a turnaround with sotagliflozin, LX9851, pilavapadin, and partnerships offering multiple ...

Pharmaceutical company AstraZeneca and the Taizhou National Medical High-tech Development Zone in Jiangsu province inked an ...

Following the FDA approval of a vagus nerve stimulator for rheumatoid arthritis, supporters of the device’s use have lauded ...

Mikael Dolsten, Pfizer's former research and development ​chief, has withdrawn his candidacy for ‌Novo Nordisk's board, ...

We congratulate Celeste Porsbjerg and colleagues for their Series paper1 addressing a key question in asthma care: the definition of the ideal candidate for biological therapy. Porsbjerg and ...